4-Phenyl-4-oxo-butanoic acid derivatives inhibitors of kynurenine 3-hydroxylase. 1998

A Giordani, and P Pevarello, and M Cini, and R Bormetti, and F Greco, and S Toma, and C Speciale, and M Varasi
Pharmacia & Upjohn, Chemistry Dept., Nerviano, Milan, Italy.

Kynurenine 3-hydroxylase (KYN 3-OHase) is a key enzyme in the kynurenine pathway of tryptophan degradation and its inhibition may be an effective mechanism for counteracting neuronal excitotoxic damage. We present here a new class of inhibitors derived from a structure-activity relationship (SAR) study of the benzoylalanine side-chain of 1. 2-hydroxy-4-(3,4-dichlorophenyl)-4-oxobutanoic acid (8) and 2-benzyl-4-(3,4-dichlorophenyl)-4-oxo-butanoic acid (10) emerged as the most interesting derivatives. Enantiospecific synthesis for both enantiomers of 8 and diastereomeric salt resolution for those of 10 were successfully applied.

UI MeSH Term Description Entries
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D010654 Phenylbutyrates Derivatives of 4-phenylbutyric acid, including its salts and esters.
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006899 Mixed Function Oxygenases Widely distributed enzymes that carry out oxidation-reduction reactions in which one atom of the oxygen molecule is incorporated into the organic substrate; the other oxygen atom is reduced and combined with hydrogen ions to form water. They are also known as monooxygenases or hydroxylases. These reactions require two substrates as reductants for each of the two oxygen atoms. There are different classes of monooxygenases depending on the type of hydrogen-providing cosubstrate (COENZYMES) required in the mixed-function oxidation. Hydroxylase,Hydroxylases,Mixed Function Oxidase,Mixed Function Oxygenase,Monooxygenase,Monooxygenases,Mixed Function Oxidases,Function Oxidase, Mixed,Function Oxygenase, Mixed,Oxidase, Mixed Function,Oxidases, Mixed Function,Oxygenase, Mixed Function,Oxygenases, Mixed Function
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014364 Tryptophan An essential amino acid that is necessary for normal growth in infants and for NITROGEN balance in adults. It is a precursor of INDOLE ALKALOIDS in plants. It is a precursor of SEROTONIN (hence its use as an antidepressant and sleep aid). It can be a precursor to NIACIN, albeit inefficiently, in mammals. Ardeydorm,Ardeytropin,L-Tryptophan,L-Tryptophan-ratiopharm,Levotryptophan,Lyphan,Naturruhe,Optimax,PMS-Tryptophan,Trofan,Tryptacin,Tryptan,Tryptophan Metabolism Alterations,ratio-Tryptophan,L Tryptophan,L Tryptophan ratiopharm,PMS Tryptophan,ratio Tryptophan
D050601 Kynurenine 3-Monooxygenase An NADPH-dependent flavin monooxygenase that plays a key role in the catabolism of TRYPTOPHAN by catalyzing the HYDROXYLATION of KYNURENINE to 3-hydroxykynurenine. It was formerly characterized as EC 1.14.1.2 and EC 1.99.1.5. Kynurenine 3-Hydroxylase,Kynurenine Hydroxylase,L-Kynurenine-3-Hydroxylase,3-Hydroxylase, Kynurenine,3-Monooxygenase, Kynurenine,Hydroxylase, Kynurenine,Kynurenine 3 Hydroxylase,Kynurenine 3 Monooxygenase,L Kynurenine 3 Hydroxylase

Related Publications

A Giordani, and P Pevarello, and M Cini, and R Bormetti, and F Greco, and S Toma, and C Speciale, and M Varasi
July 2014, Acta crystallographica. Section E, Structure reports online,
A Giordani, and P Pevarello, and M Cini, and R Bormetti, and F Greco, and S Toma, and C Speciale, and M Varasi
November 2013, Acta crystallographica. Section E, Structure reports online,
A Giordani, and P Pevarello, and M Cini, and R Bormetti, and F Greco, and S Toma, and C Speciale, and M Varasi
February 1999, Chemical research in toxicology,
A Giordani, and P Pevarello, and M Cini, and R Bormetti, and F Greco, and S Toma, and C Speciale, and M Varasi
January 1991, Journal of enzyme inhibition,
A Giordani, and P Pevarello, and M Cini, and R Bormetti, and F Greco, and S Toma, and C Speciale, and M Varasi
September 1997, Acta crystallographica. Section C, Crystal structure communications,
A Giordani, and P Pevarello, and M Cini, and R Bormetti, and F Greco, and S Toma, and C Speciale, and M Varasi
August 2008, Acta crystallographica. Section E, Structure reports online,
A Giordani, and P Pevarello, and M Cini, and R Bormetti, and F Greco, and S Toma, and C Speciale, and M Varasi
January 2013, Acta crystallographica. Section E, Structure reports online,
A Giordani, and P Pevarello, and M Cini, and R Bormetti, and F Greco, and S Toma, and C Speciale, and M Varasi
April 2011, Drug discoveries & therapeutics,
A Giordani, and P Pevarello, and M Cini, and R Bormetti, and F Greco, and S Toma, and C Speciale, and M Varasi
March 2015, Bioorganic & medicinal chemistry,
A Giordani, and P Pevarello, and M Cini, and R Bormetti, and F Greco, and S Toma, and C Speciale, and M Varasi
March 1999, Farmaco (Societa chimica italiana : 1989),
Copied contents to your clipboard!